CLRB
CLRBCIK 0001279704
Micro by assets
Assets $37M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
8-K
Filed Aug 13, 2026
· Period ending Aug 13, 2026
Summary not yet generated.
10-Q
Filed Aug 13, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
Partner
Trade CLRB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jul 10, 2026
· Period ending Jul 7, 2026
Summary not yet generated.
S-1/A
Filed May 29, 2026
Red flag
Cellectar registers up to 52M shares for resale by selling stockholders; company offers no shares
6 material changes detected. Sign up free to read the summary.
8-K
Filed May 18, 2026
· Period ending May 17, 2026
Summary not yet generated.
8-K
Filed May 14, 2026
· Period ending May 14, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| OPERATING EXPENSES: | ||||
| Research and development | 4,557,383 | 2,389,801 | 7,564,612 | 5,816,896 |
| General and administrative | 2,638,629 | 3,647,728 | 5,425,341 | 6,621,624 |
| Total operating expenses | 7,196,012 | 6,037,529 | 12,989,953 | 12,438,520 |
| LOSS FROM OPERATIONS | (7,196,012) | (6,037,529) | (12,989,953) | (12,438,520) |
| OTHER INCOME (EXPENSE): | ||||
| Gain (loss) on valuation of warrants | 132,000 | 501,598 | 209,000 | 161,598 |
| Interest income | 133,359 | 88,020 | 196,355 | 224,982 |
| Total other income (expense) | 265,359 | 589,618 | 405,355 | 386,580 |
| NET LOSS | (6,930,653) | (5,447,911) | (12,584,598) | (12,051,940) |
| NET LOSS PER SHARE BASIC | (0.57) | (3.39) | (1.52) | (7.66) |
| NET LOSS PER SHARE DILUTED | (0.57) | (3.39) | (1.52) | (7.66) |
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC | 12,231,851 | 1,608,799 | 8,258,067 | 1,572,598 |
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED | 12,231,851 | 1,608,799 | 8,258,067 | 1,572,598 |
Condensed Consolidated Balance Sheets (Unaudited)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | 33,993,982 | 13,196,033 |
| Prepaid expenses and other current assets | 883,659 | 842,432 |
| Total current assets | 34,877,641 | 14,038,465 |
| Property, plant & equipment, net | 304,173 | 549,405 |
| Operating lease right-of-use asset | 1,433,706 | 360,671 |
| Other long-term assets | 23,566 | 29,780 |
| TOTAL ASSETS | 36,639,086 | 14,978,321 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accrued liabilities | 5,218,681 | 4,423,548 |
| Warrant liability | 17,000 | 226,000 |
| Lease liability, current | 2,030 | 100,189 |
| Total current liabilities | 5,237,711 | 4,749,737 |
| Lease liability, net of current portion | 1,529,542 | 309,397 |
| TOTAL LIABILITIES | 6,767,253 | 5,059,134 |
| COMMITMENTS AND CONTINGENCIES (Note 7) | ||
| MEZZANINE EQUITY: | ||
| Series D preferred stock, 111.11 shares authorized, 0.00 and 111.11 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | — | 1,382,023 |
| STOCKHOLDERS’ EQUITY: | ||
| Series E-2 preferred stock, 1,225 shares authorized; 0.00 and 35.60 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | — | 520,778 |
| Common stock, $0.00001 par value; 170,000,000 shares authorized; 8,252,108 and 4,240,129 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 83 | 42 |
| Additional paid-in capital | 311,589,849 | 277,149,844 |
| Accumulated deficit | (281,718,099) | (269,133,500) |
| Total stockholders’ equity | 29,871,833 | 8,537,164 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 36,639,086 | 14,978,321 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | (12,584,598) | (12,051,940) |
| Adjustments to reconcile net loss to cash used in operating activities: | ||
| Depreciation and amortization | (74,494) | 111,859 |
| Stock-based compensation expense | 880,175 | 1,128,128 |
| Change in operating lease right-of-use asset | 46,204 | 36,626 |
| Change in fair value of warrants | (209,000) | (161,598) |
| Changes in: | ||
| Prepaid expenses and other current assets | 288,091 | (614,914) |
| Lease liability | 2,747 | (40,494) |
| Accounts payable and accrued liabilities | 795,133 | (2,906,627) |
| Cash used in operating activities | (10,855,742) | (14,498,960) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchases of property, plant & equipment | (3,378) | — |
| Cash used in investing activities | (3,378) | — |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from exercise of warrants, net of issuance costs (Note 2) | 3 | 2,251,380 |
| Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs (Note 2) | 31,657,066 | — |
| Cash provided by financing activities | 31,657,069 | 2,251,380 |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | 20,797,949 | (12,247,580) |
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 13,196,033 | 23,288,607 |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | 33,993,982 | 11,041,027 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||
| Settlement of warrants to equity | — | 462,760 |
| Conversion of preferred stock to common stock | 1,902,801 | — |
| Value of warrants issued to placement agent | 1,473,793 | — |
| Right of use asset obtained in exchange for operating lease liability | 1,119,239 | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗